Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Knowledge, Attitude and Practice on Maternal Immunization with Tetanus Toxoid, Reduced Diphtheria Toxoid, and Aellular Pertussis (Tdap) among Pregnant Women

임신 중 Tdap 접종에 대한 임부들의 인식, 태도 및 행동

  • Lee, Shin-Hye (Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Jin, Bo-Kyeung (Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Baek, Kyeung-Suk (Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Cho, Yong-Sun (Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Lee, Taek-Jin (Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine)
  • 이신혜 (차의과학대학교 분당차병원 소아청소년과) ;
  • 진보경 (차의과학대학교 분당차병원 소아청소년과) ;
  • 백경숙 (차의과학대학교 분당차병원 소아청소년과) ;
  • 조용선 (차의과학대학교 분당차병원 소아청소년과) ;
  • 이택진 (차의과학대학교 분당차병원 소아청소년과)
  • Received : 2018.07.11
  • Accepted : 2018.08.23
  • Published : 2018.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Despite effectiveness and safety of maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination, Tdap vaccination coverage during pregnancy remains quite low. We assessed the knowledge, attitude and practice on maternal Tdap vaccination among pregnant women. Methods: This study was a cross-sectional survey of pregnant women who visited tertiary obstetrics and gynecologic units in Seoul and Gyeonggi province of Korea. Individual questionnaires were administered to assess knowledge, attitude and practice on maternal immunization with Tdap. Results: The questionnaires were completed by 184 pregnant women; 158 (86%) had not received information from doctors about pertussis and Tdap, and 166 (90%) did not know the need for Tdap vaccination. Only 7% of pregnant women unlikely to receive Tdap vaccine during current pregnancy answered 3 or more of the 5 knowledge-based questions correctly. By logistic regression analysis, recommendation by doctor (adjusted odd ratio [OR], 236.2; 95% confidence interval [CI], 12.6-4,432), belief that the vaccine is effective (adjusted OR, 40.21; 95% CI, 2.35-687.7), and belief that the vaccine is safe (adjusted OR, 19.83; 95% CI, 1.54-255.9) were significantly important factors to respondents' intention to be vaccinated. Conclusions: Most pregnant women seem to be neither recommended nor adequately informed about Tdap vaccination. Information given by health care professionals is very important to increase Tdap coverage among pregnant women.

목적: 임신 중 tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) 접종의 효과 및 안전성에도 불구하고, 아직 국내 임신 중 Tdap 접종률은 낮다. 이에 저자들은 임신 중 Tdap 접종에 대한 임부들의 인식, 태도 및 행동에 대한 조사를 하였다. 방법: 본 연구는 서울 및 경기 소재 대학병원 산부인과를 방문한 임부를 대상으로 개별적인 설문지를 통해 임신 중 Tdap 접종에 대한 인식, 태도 및 행동을 수집한 단면 설문조사다. 결과: 총 184명의 임부들이 설문지 작성을 완료하였다. 이 중 158명(86%)의 임부들은 의사로부터 백일해 및 Tdap 백신에 대한 정보를 안내 받지 못했고, 166명(90%)의 임부들은 임신 중 Tdap 접종의 필요성을 알지 못했다. 현 임신기간 중 Tdap 접종을 하지 않을 것이라고 답한 임부 중 7%만이 백일해 및 백신에 대한 이해를 묻는 5문항 중 3문항 이상 올바르게 답하였다. 로지스틱 회귀분석에서 의사의 추천(adjusted odds ratio [OR], 236.2; 95% confidence interval [CI], 12.6-4,432), 백신이 효과적이라는 믿음(adjusted OR, 40.21; 95% CI, 2.35-687.7), 백신이 안전하다는 믿음(adjusted OR, 19.83; 95% CI, 1.54-255.9) 등이 Tdap 접종을 결정하는데 유의하게 중요한 요인이었다. 결론: 대부분의 임부들이 Tdap 접종에 대하여 적절하게 안내를 받지 못하거나, 추천받지 못하는 것으로 보인다. 임부들의 Tdap 접종률을 향상시키는 데에 의료기관 종사자에 의해 제공되는 정보가 매우 중요하다.

Keywords

References

  1. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003;290:2968-75. https://doi.org/10.1001/jama.290.22.2968
  2. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131-5.
  3. Choe YJ, Park YJ, Jung C, Bae GR, Lee DH. National pertussis surveillance in South Korea 1955-2011: epidemiological and clinical trends. Int J Infect Dis 2012;16:e850-4. https://doi.org/10.1016/j.ijid.2012.07.012
  4. The Korean Pediatric Society. DTaP, Tdap, Td vaccine. In: Lee HJ, editor. Immunization guideline. 8th ed. Seoul: The Korean Pediatric Society, 2015:187-202.
  5. Kim IS, Seo YB, Hong KW, Noh JY, Choi WS, Song JY, et al. Perceptions of tetanus-diphteria-acellular pertussis (Tdap) vaccination among Korean women of childbearing age. Infect Chemother 2013;45:217-24. https://doi.org/10.3947/ic.2013.45.2.217
  6. Ministry of Health and Welfare; Korea Centers for Disease Control & Prevention. Infectious Diseases Surveillance Yearbook, 2017. Cheongju: Korea Centers for Disease Control & Prevention; 2018.
  7. Choe YJ, Kim JW, Park YJ, Jung C, Bae GR. Burden of pertussis is underestimated in South Korea: a result from an active sentinel surveillance system. Jpn J Infect Dis 2014;67:230-2. https://doi.org/10.7883/yoken.67.230
  8. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014;209:978-81. https://doi.org/10.1093/infdis/jiu001
  9. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014;384:1521-8. https://doi.org/10.1016/S0140-6736(14)60686-3
  10. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011;204:334.e1-5. https://doi.org/10.1016/j.ajog.2010.11.024
  11. Leuridan E, Hens N, Peeters N, de Witte L, Van der Meeren O, Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011;30:608-10. https://doi.org/10.1097/INF.0b013e3182093814
  12. Winter K, Cherry JD, Harriman K. Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants. Clin Infect Dis 2017;64:9-14. https://doi.org/10.1093/cid/ciw633
  13. Winter K, Nickell S, Powell M, Harriman K. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis 2017;64:3-8. https://doi.org/10.1093/cid/ciw634
  14. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA 2014;312:1897-904. https://doi.org/10.1001/jama.2014.14825
  15. Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014;349:g4219. https://doi.org/10.1136/bmj.g4219
  16. Moro PL, McNeil MM, Sukumaran L, Broder KR. The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States. Hum Vaccin Immunother 2015;11:2872-9. https://doi.org/10.1080/21645515.2015.1072664
  17. Choi WS, Choi JH, Kwon KT, Seo K, Kim MA, Lee SO, et al. Revised adult immunization guideline recommended by the Korean society of infectious diseases, 2014. Infect Chemother 2015;47:68-79. https://doi.org/10.3947/ic.2015.47.1.68
  18. Seo J, Lim J. Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: effect of public health policies on vaccination behavior. Vaccine 2018;36:3666-73. https://doi.org/10.1016/j.vaccine.2018.05.024
  19. Noh JY, Seo YB, Song JY, Choi WS, Lee J, Jung E, et al. Perception and attitudes of Korean obstetricians about maternal influenza vaccination. J Korean Med Sci 2016;31:1063-8. https://doi.org/10.3346/jkms.2016.31.7.1063